NCT02230683 A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension Status COMPLETED Phase PHASE2
NCT02226939 Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Cirrhosis and Chronic Hepatitis C Status COMPLETED Phase PHASE2
NCT02221570 Baclofen in the Treatment of Muscle Cramps in Patients With Cirrhosis Status UNKNOWN Phase NA
NCT02178319 Laparoscopic Versus Open Devascularization for Portal Hypertension, a Randomized Controlled Trial Status UNKNOWN Phase NA
NCT02156232 Embolization of Large Spontaneous Portosystemic Shunts for the Prevention of Post-TIPS Hepatic Encephalopathy Status COMPLETED Phase NA
NCT02138253 A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV Status COMPLETED Phase PHASE2
NCT02125071 Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver Transplantation Status COMPLETED Phase N/A
NCT02120196 Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial Peritonitis Status UNKNOWN Phase PHASE3
NCT02119988 TIPS Combined With Variceal Embolization for the Prevention of Variceal Rebleeding in Patients With Cirrhosis Status COMPLETED Phase NA
NCT02073435 A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation Status COMPLETED Phase N/A
NCT02069457 Prevalence and Predictive Factors of Portal Vein Thrombosis in Patients With Cirrhosis Status COMPLETED Phase N/A
NCT02048969 Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS Status WITHDRAWN Phase PHASE1/PHASE2
NCT02023229 Branched Chain Aminoacid Supplementation in Patients With Liver Cirrhosis Status COMPLETED Phase PHASE4
NCT02023190 Changes in Body Composition and Nutritional Status in Patients Undergoing Liver Transplantation Status UNKNOWN Phase N/A